Creeping fat, a type of abnormal adipose tissue, harbors mechanosensitive fibroblasts capable of generating connective tissue contributing to intestinal fibrosis in Crohn’s disease.

With over 98% agreement with ELISA, the LEO system offers a fast, reliable method for gluten testing, supporting safer food choices for sensitive individuals.

New report highlights cost, coverage and prior authorization barriers, with technology seen as a potential solution.

Hartmann et al. use ultra-high field 7 T fMRI to investigate shared neurobiological mechanisms between Crohn’s disease (CD) and major depressive disorder (MDD). Their findings reveal overlapping abnormalities in brain activity and connectivity, suggesting a neuropsychological link that may inform integrated treatment strategies.

An Adelaide-based research collaboration has identified the specific nerve pathways responsible for relaying pain signals from the bowel to the brain, paving the way for new irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) treatments.

A global consensus overrides fear of harming the fetus and makes some novel recommendations for the use of medication during pregnancy.

Biases observed in gastroenterologists toward patients with IBS originate as early as the beginning of medical school, including seeing IBS as a "less real" disease and more difficult to treat. Earlier educational interventions may be helpful in identifying and addressing these biases.

Despite the increased use of advanced medical therapies in Crohn’s disease, the 5-year rate of a third surgery remains unchanged in patients who have undergone a second surgery.